Sociodemographic, health care, and clinical factors are associated with receipt of semaglutide in those with obesity but without diabetes.
The Inflation Reduction Act (IRA), passed in 2022, made changes to the way drugs are covered and reimbursed in Medicare.
Some results have been hidden because they may be inaccessible to you
Show inaccessible results
Feedback